Double-Digit Growth in Reported and Adjusted Revenue Sensient Operating at or Above its 2022 Guidance MILWAUKEE–(BUSINESS WIRE)–Sensient Technologies Corporation (NYSE: SXT) reported consolidated revenue of $371.7 million in this year’s second quarter compared to $335.8 million in last year’s second quarter. Reported operating income in the second quarter of 2022 was $55.2 million compared to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization” report has been added to ResearchAndMarkets.com’s offering. Make investment decisions and valuations with confidence using the latest data and 5 year forecasts Diagnostics are leading the charge in reducing the threat posed by antimicrobial resistance. Will these … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Emerging Singlecell Technology Startups 2022” report has been added to ResearchAndMarkets.com’s offering. The global single-cell technology (SCT) market has emerged since the mid-2010s. The SCT is defined as any cell biology research tool that provides single cell resolution handling and data sets, for example, single cell (SC) picking up/dispensing, SC-sequencing, and SC-protein analysis … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “UAE Cancer Diagnostics Market, By Product (Consumable v/s Instruments), By Technology, By Application, By End User, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. The UAE cancer diagnostics market is expected to grow at a steady rate in the forecast period. The market growth can be attributed … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Autoinjectors Market, By Therapy By Design By Product By Technology By Type By Route of Administration By End User By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The global autoinjectors market is expected to witness a growth of robust CAGR in the forecast period, 2023-2027. Companies … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “UAE Glucometers Market, By Product Type (Self Glucose Monitoring Glucometers v/s Continuous Glucose Monitoring Glucometers), By Technique (Invasive v/s Non-Invasive), By Type, By Distribution Channel, By End User, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. UAE glucometers market is estimated to grow at a formidable CAGR … [Read more…]
UK-based programming is free for anyone with 48 hours of continuous sobriety and will begin to be held monthly as The Phoenix broadens its reach globally through volunteer-led classes DENVER–(BUSINESS WIRE)–The Phoenix, a nonprofit organization that fosters a supportive, sober active community for individuals recovering from substance use as well as allies and supporters of … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “United Kingdom Glucometers Market, By Product Type (Self Glucose Monitoring Glucometers v/s Continuous Glucose Monitoring Glucometers), By Technique, By Type, By Distribution Channel, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. United Kingdom glucometers market is expected to witness robust growth in the forecast … [Read more…]
WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today criticized the trade association for the greediest, most profitable industry on the planet for hypocritically crying out for so-called “drug price fairness” in a full-page ad about the 340B drug pricing program that ran earlier this week in the Washington Post. The cynical ad was placed by the Pharmaceutical … [Read more…]
BEIJING–(BUSINESS WIRE)–InnoCare (HKEX: 09969) today announced that tafasitamab (Minjuvi®) in combination with lenalidomide has been approved by the Health Commission and Medical Products Administration of Hainan Province, under the early access program in Boao Lecheng International Medical Tourism Pilot Zone, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) … [Read more…]
